Abbott Laboratories CDR (ABL0)
Market Closed
3 Jun, 20:00
XFRA XFRA Primary 
NEO-L €
9. 4500
-0.1
-1.05%
€
126.23B Market Cap
36.49 P/E Ratio
0.28% Div Yield
40 Volume
4.44 Eps
€ 9.55
Previous Close Want to track ABL0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Abbott Laboratories CDR (ABL0) Statistics
Valuation metrics
Market Cap 126.23B
Enterprise value 37.51B
Trailing P/E (ttm) 23.72
Forward P/E -
PEG ratio -1.27
Price/Sales (ttm) 2.75
Price/Book (mrq) 1.45
Enterprise Value/Revenue 0.97
Enterprise Value/EBITDA 3.71
Overview
Shares outstanding 1.74B
Float 1.73B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 32
Average volume (90 days) 27
Price summary
52-Week low 9.2
52-Week high 16
Beta 0.65
50-Day moving average 11
200-Day moving average 12.94
Dividends and splits
Forward annual dividend rate 0.28
Forward annual dividend yield 0.0285%
Trailing annual dividend rate 0.2
Trailing annual dividend yield 0.0208%
5-Year annual dividend yield -
Payout ratio 0.5
Dividend Date 22 Apr 2026
Ex-Dividend Date 15 Apr 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.14%
Operating margin 0.13%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.12%
Income Statement
Revenue (ttm) 38.84B
Revenue per share (ttm) 6.48
Quarterly revenue growth (yoy) 0.08%
Gross profit (ttm) 21.94B
EBITDA 11.78B
Net income to common (ttm) 5.38B
Diluted EPS (ttm) 0.39
Quarterly earnings growth (yoy) -0.19%
Balance Sheet
Total cash (mrq) 6.28B
Total cash per share (mrq) 4.19
Total debt (mrq) 29.37B
Total Debt/Equity (mrq) 64.77
Current ratio (mrq) 1.39%
Book value per share (mrq) 6.37
Cash Flow
Cash flow statement 8.14B
Levered free cash flow (LFCF) 5.46B
